← brief for 2026-08-12 · Slowing decline

Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with CKD

Paper C Peer reviewed Observational

Key takeaways

This compared kidney outcomes in people with kidney disease who took triglyceride-lowering drugs versus statins. Both are used to lower fats in the blood. Because it compares people already taking these drugs, it shows a link, not proof. It points at whether one type protects the kidneys more.

Who did this work

M. Naim (University of Tennessee Health Science Center) · Fridtjof Thomas (University of Tennessee Health Science Center) · Elani Streja (University of California, Irvine) · Robert L. Davis (University of Tennessee Health Science Center) · Kamyar Kalantar-Zadeh (West Los Angeles College) · Keiichi Sumida (University of Tennessee Health Science Center) · Csaba P. Kövesdy (University of Tennessee Health Science Center)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-11
https://doi.org/10.2215/cjn.0000001188